|
Real-time
Boerse Muenchen
11:13:58 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 184.95 EUR | 0.00% |
|
+0.65% | +43.76% |
| 08-12 | UBS Adjusts Price Target on Axsome Therapeutics to $280 From $259, Keeps Buy Rating | MT |
| 08-12 | Mizuho Adjusts PT on Axsome Therapeutics to $316 From $306, Keeps Outperform Rating | MT |
| Market Cap | 11.19B 9.67B 9.08B 8.26B 15.53B 1,070B 15.79B 106B 41.61B 536B 42.02B 41.11B 1,781B | P/E 2026 * |
-80.2x | P/E 2027 * | 45.8x |
|---|---|---|---|---|---|
| Enterprise Value | 11.04B 9.53B 8.96B 8.15B 15.31B 1,055B 15.57B 105B 41.03B 528B 41.43B 40.53B 1,756B | EV / Sales 2026 * |
11.4x | EV / Sales 2027 * | 6.89x |
| Free-Float |
84.63% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Axsome Therapeutics, Inc.
| 1 week | +0.65% | ||
| Current month | -2.27% | ||
| 1 month | -10.17% | ||
| 3 months | -6.83% | ||
| 6 months | +20.80% | ||
| Current year | +43.76% |
| 1 week | 179.85 |  | 196.75 |
| 1 month | 179.85 | | 218.9 |
| 3 years | 52.74 | | 225.3 |
| 5 years | 16.81 | | 225.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 11/01/2012 | |
Nick Pizzie
DFI | Director of Finance/CFO | 51 | 15/05/2018 |
Mark Jacobson
COO | Chief Operating Officer | 42 | 31/03/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 11/01/2012 | |
Roger Jeffs
BRD | Director/Board Member | 64 | 30/11/2014 |
Mark Coleman
BRD | Director/Board Member | 58 | 30/11/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +0.65% | +98.40% | +179.97% | 11.19B | |
| -0.31% | +2.44% | +38.43% | +0.77% | 80.23B | |
| -1.02% | -0.51% | -2.54% | +28.91% | 50.64B | |
| +1.41% | -4.35% | +10.16% | +164.43% | 46.87B | |
| -1.39% | +0.10% | -50.39% | -50.07% | 46.34B | |
| -0.39% | +0.91% | +51.39% | -20.90% | 31B | |
| -0.52% | +7.01% | +125.98% | -35.99% | 25.28B | |
| -0.30% | -0.33% | +38.24% | +85.63% | 24.36B | |
| +1.65% | -2.00% | -6.43% | +191.59% | 20.81B | |
| +3.02% | +0.53% | +61.14% | +118.11% | 16.08B | |
| Average | +0.37% | +0.35% | +36.44% | +66.25% | 37.96B | |
| Weighted average by Cap. | +0.02% | +0.53% | +24.82% | +43.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 971M 839M 788M 717M 1.35B 92.85B 1.37B 9.23B 3.61B 46.5B 3.65B 3.57B 155B | 1.56B 1.35B 1.27B 1.15B 2.17B 149B 2.2B 14.86B 5.81B 74.8B 5.87B 5.74B 249B |
| Net income | -140M -121M -113M -103M -194M -13.35B -197M -1.33B -519M -6.69B -524M -513M -22.22B | 259M 223M 210M 191M 359M 24.74B 365M 2.46B 962M 12.39B 971M 950M 41.17B |
| Net Debt | -156M -135M -127M -115M -217M -14.96B -221M -1.49B -582M -7.49B -587M -575M -24.9B | -435M -376M -353M -321M -604M -41.63B -614M -4.14B -1.62B -20.85B -1.63B -1.6B -69.27B |
| Date | Price | Change |
|---|---|---|
| 17/08/26 | €184.95 | 0.00% |
| 14/08/26 | €184.95 | 0.00% |
| 13/08/26 | €184.95 | -0.51% |
| 12/08/26 | €185.90 | -0.72% |
| 11/08/26 | €187.25 | -1.89% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AXSM Stock
- 19X Stock
Select your edition
All financial news and data tailored to specific country editions
